Leukemia inhibitory factor and oncostatin M influence the mineral phases formed in a murine heterotopic calcification model: A Fourier transform infrared microspectroscopic study

被引:12
作者
Bohic, S
Rohanizadeh, R
Touchais, S
Godard, A
Daculsi, G
Heymann, D
机构
[1] Fac Chirurg Dent, UPRES EA 2159, Ctr Rech Interdisciplinaire Tissus Calcifies & Bi, Nantes 01, France
[2] CHRU, Serv Chirurg Orthoped, Nantes, France
[3] Inst Biol, INSERM U463, Nantes, France
关键词
D O I
10.1359/jbmr.1998.13.10.1619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The study of bone mineralization processes is of considerable interest in understanding bone diseases and developing new therapies for skeletal disorders, particularly since bone homeostasis requires numerous cell types and a large cytokine network Cell culture models of mineralization have often been used to study the cellular mechanisms of mineralization, but few data have been reported concerning the influence of extracellular matrix components and cytokines on the physicochemical properties of mineral. The purpose of this study was to analyze the effects of two cytokines, leukemia inhibitory factor (LIF) and oncostatin M (OSM), involved in bone metabolism on the physicochemical properties of bone mineral formed in a murine in vivo mineralization model. Murine bone marrow cells implanted under the kidney capsule in the presence or absence of cytokines led to heterotopic ossicle formation. A scanning electron microscopic microprobe revealed that heterotopic calcification had a lower (similar to 20%) Ca/P ratio after cytokine treatment as compared with the control without cytokine, Transmission electron microscopic analysis of cytokine-treated ossicles showed numerous areas with low mineral density, whereas electron diffraction pattern revealed an apatitic phase. These areas were not observed in the absence of cytokine, Moreover, Fourier transform-infrared microspectroscopy showed at the molecular level that the presence of either cytokine induced many microscopic areas in which short-range order organization, such as incorporation of carbonate and crystallinity/maturity of ossicle mineral, were modified. LIF and OSM influenced mineral phase formation in the present model and may thus be key protagonists in bone mineral development and skeletal diseases.
引用
收藏
页码:1619 / 1632
页数:14
相关论文
共 55 条
  • [1] Alsina M, 1996, VITAM HORM, V52, P63, DOI 10.1016/S0083-6729(08)60407-0
  • [2] PRODUCTION OF HUMAN INTERLEUKIN FOR DA CELLS (HILDA) LEUKEMIA INHIBITORY FACTOR (LIF) BY ACTIVATED MONOCYTES
    ANEGON, I
    MOREAU, JF
    GODARD, A
    JACQUES, Y
    PEYRAT, MA
    HALLET, MM
    WONG, G
    SOULILLOU, JP
    [J]. CELLULAR IMMUNOLOGY, 1990, 130 (01) : 50 - 65
  • [3] Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal osteoblastic cells
    Bellido, T
    Stahl, N
    Farruggella, TJ
    Borba, V
    Yancopoulos, GD
    Manolagas, SC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) : 431 - 437
  • [4] CHEMICAL AND STRUCTURAL STUDY OF THE MINERAL PHASE ASSOCIATED WITH A HUMAN SUBCUTANEOUS ECTOPIC CALCIFICATION
    BIGI, A
    FORESTI, E
    INCERTI, A
    ROVERI, N
    BOREA, PA
    ZAVAGLI, G
    [J]. INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1980, 46 (06): : 271 - 274
  • [5] THE ROLE OF MAGNESIUM ON THE STRUCTURE OF BIOLOGICAL APATITES
    BIGI, A
    FORESTI, E
    GREGORINI, R
    RIPAMONTI, A
    ROVERI, N
    SHAH, JS
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (05) : 439 - 444
  • [6] BOSKEY AL, 1992, CELL MATER, V2, P209
  • [7] Matrix proteins and mineralization: An overview
    Boskey, AL
    [J]. CONNECTIVE TISSUE RESEARCH, 1996, 35 (1-4) : 357 - 363
  • [8] BROWN TJ, 1987, J IMMUNOL, V139, P2977
  • [9] Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy
    Camacho, NP
    Landis, WJ
    Boskey, AL
    [J]. CONNECTIVE TISSUE RESEARCH, 1996, 35 (1-4) : 259 - 265
  • [10] Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8